These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 29029799)

  • 1. Interdependent and independent multidimensional role of tumor microenvironment on hepatocellular carcinoma.
    Wang X; Hassan W; Jabeen Q; Khan GJ; Iqbal F
    Cytokine; 2018 Mar; 103():150-159. PubMed ID: 29029799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exosome-mediated communication in the tumor microenvironment contributes to hepatocellular carcinoma development and progression.
    Wu Q; Zhou L; Lv D; Zhu X; Tang H
    J Hematol Oncol; 2019 May; 12(1):53. PubMed ID: 31142326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Components of the Hepatocellular Carcinoma Microenvironment and Their Role in Tumor Progression.
    Novikova MV; Khromova NV; Kopnin PB
    Biochemistry (Mosc); 2017 Aug; 82(8):861-873. PubMed ID: 28941454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic modulators of hepatic stellate cells for hepatocellular carcinoma.
    Ruan Q; Wang H; Burke LJ; Bridle KR; Li X; Zhao CX; Crawford DHG; Roberts MS; Liang X
    Int J Cancer; 2020 Sep; 147(6):1519-1527. PubMed ID: 32010970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current perspectives on the immunosuppressive tumor microenvironment in hepatocellular carcinoma: challenges and opportunities.
    Lu C; Rong D; Zhang B; Zheng W; Wang X; Chen Z; Tang W
    Mol Cancer; 2019 Aug; 18(1):130. PubMed ID: 31464625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of tumor-associated macrophages in hepatocellular carcinoma: impact, mechanism, and therapy.
    Zhang Y; Han G; Gu J; Chen Z; Wu J
    Front Immunol; 2024; 15():1429812. PubMed ID: 39170620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting Tumor Immunosuppressive Microenvironment for the Prevention of Hepatic Cancer: Applications of Traditional Chinese Medicines in Targeted Delivery.
    Zhang LY; Zhang JG; Yang X; Cai MH; Zhang CW; Hu ZM
    Curr Top Med Chem; 2020; 20(30):2789-2800. PubMed ID: 33076809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global research trends in the tumor microenvironment of hepatocellular carcinoma: insights based on bibliometric analysis.
    Han H; Zhao Z; He M; Guan G; Cao J; Li T; Han B; Zhang B
    Front Immunol; 2024; 15():1474869. PubMed ID: 39411719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delineation of an immunosuppressive gradient in hepatocellular carcinoma using high-dimensional proteomic and transcriptomic analyses.
    Chew V; Lai L; Pan L; Lim CJ; Li J; Ong R; Chua C; Leong JY; Lim KH; Toh HC; Lee SY; Chan CY; Goh BKP; Chung A; Chow PKH; Albani S
    Proc Natl Acad Sci U S A; 2017 Jul; 114(29):E5900-E5909. PubMed ID: 28674001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The tumor microenvironment in hepatocellular carcinoma: current status and therapeutic targets.
    Yang JD; Nakamura I; Roberts LR
    Semin Cancer Biol; 2011 Feb; 21(1):35-43. PubMed ID: 20946957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor Microenvironment, a Paradigm in Hepatocellular Carcinoma Progression and Therapy.
    Tahmasebi Birgani M; Carloni V
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28216578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological Microenvironment of Hepatocellular Carcinoma and Its Clinical Implication.
    Nishida N; Kudo M
    Oncology; 2017; 92 Suppl 1():40-49. PubMed ID: 27764823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer-associated fibroblasts in hepatocellular carcinoma.
    Kubo N; Araki K; Kuwano H; Shirabe K
    World J Gastroenterol; 2016 Aug; 22(30):6841-50. PubMed ID: 27570421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NETosis in tumour microenvironment of liver: From primary to metastatic hepatic carcinoma.
    Yang Y; Yu S; Lv C; Tian Y
    Ageing Res Rev; 2024 Jun; 97():102297. PubMed ID: 38599524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity of cancer-associated fibroblasts and roles in the progression, prognosis, and therapy of hepatocellular carcinoma.
    Yin Z; Dong C; Jiang K; Xu Z; Li R; Guo K; Shao S; Wang L
    J Hematol Oncol; 2019 Sep; 12(1):101. PubMed ID: 31547836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three Dimensional Mixed-Cell Spheroids Mimic Stroma-Mediated Chemoresistance and Invasive Migration in hepatocellular carcinoma.
    Khawar IA; Park JK; Jung ES; Lee MA; Chang S; Kuh HJ
    Neoplasia; 2018 Aug; 20(8):800-812. PubMed ID: 29981501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor regulation of the tissue environment in the liver.
    Eggert T; Greten TF
    Pharmacol Ther; 2017 May; 173():47-57. PubMed ID: 28167218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocellular carcinoma cells and their fibrotic microenvironment modulate bone marrow-derived mesenchymal stromal cell migration in vitro and in vivo.
    Garcia MG; Bayo J; Bolontrade MF; Sganga L; Malvicini M; Alaniz L; Aquino JB; Fiore E; Rizzo MM; Rodriguez A; Lorenti A; Andriani O; Podhajcer O; Mazzolini G
    Mol Pharm; 2011 Oct; 8(5):1538-48. PubMed ID: 21770423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic stellate cells and extracellular matrix in hepatocellular carcinoma: more complicated than ever.
    Carloni V; Luong TV; Rombouts K
    Liver Int; 2014 Jul; 34(6):834-43. PubMed ID: 24397349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune control in hepatocellular carcinoma development and progression: role of stromal cells.
    Sprinzl MF; Galle PR
    Semin Liver Dis; 2014 Nov; 34(4):376-88. PubMed ID: 25369300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.